This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Clinical
Getting closer to finding out why the immune system attacks itself
Read more
Researchers develop first functional targeted inhibitors of peanut allergens
Read more
First results of a major three-year project to analyse airborne grass pollen
Read more
Antibiotics available in some OTC throat medications could contribute to increased antibiotic resistance
Read more
ESMO drives EU-level action to tackle shortages of essential medicines
Read more
Lynparza approved in EU for germline BRCA-mutated HER2-negative metastatic breast cancer
Read more
Hep C infections could be prevented worldwide by reducing transmission in people who inject drugs
Read more
Homeopathy prescribing set to be blacklisted under NHS England plans
Read more
Researchers publish interim advice on prescribing cannabis-based products for medicinal use
Read more
Unlocking the female bias in lupus
Read more
First European framework contracts for influenza pandemic preparedness awarded
Read more
2019 update of the EULAR recommendations for the management of SLE
Read more
New treatment combination available first-line to treat advanced kidney cancer
Read more
Warnings over fluoroquinolone antibiotics after reports of ‘irreversible’ side effects
Read more
Bronchiectasis associated with high frequency of allergy
Read more
Expert analysis: Transition from childhood to adult care in coeliac disease
Read more
Expert view: Refining the use of belimumab in patients with SLE
Read more
Page 109 of 200
« First
«
...
10
20
30
...
107
108
109
110
111
...
120
130
140
...
»
Last »
Popular articles
Third of patients in favour of AI-supported consultations and clinical documents, study finds
18 April, 2024
Telemedicine strategy post-acute coronary syndrome drives efficiencies and safety, study finds
17 April, 2024
Bimekizumab gains EC approval for hidradenitis suppurativa
22 April, 2024
x
Search for: